Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Netia Medical Technologies - aVenture Company Research

Netia Medical Technologies

Netia Medical Technologies

Netia, a Nebraska-based medical firm, licenses its patented RNAi drug development platform for cost-effective, faster, and versatile pharmaceutical solutions.

Omaha, NE, US🇺🇸

Founded

Netia Medical Technologies, based in Omaha, Nebraska, is dedicated to revolutionizing drug development through its innovative RNAi platform. The company's core mission is to provide cost-effective, faster, and versatile pharmaceutical solutions by licensing its patented single-strand RNAi drug development technology. This platform significantly reduces the time and cost required to bring new drugs to market, making it a valuable asset for pharmaceutical companies and academic groups focused on translational research.

Netia's technology is supported by six patent filings and has the potential to address 'undruggable' targets, thereby expanding the scope of treatable conditions. The company has garnered attention for its ability to cut conventional drug development costs by more than half and reduce the time to market by three years. This impact positions Netia as a transformative player in the pharmaceutical industry, driving advancements in medical research and therapeutic solutions.

Netia Medical Technologies - Similar Companies

Nymirum

Net Medical Xpress Solutions

netmedical.com

Ribometrix

ribometrix.com

Netia Medical Technologies - Quick Facts

Who are Netia Medical Technologies' competitors?

Companies similar to Netia Medical Technologies include Nymirum, Net Medical Xpress Solutions, Ribometrix and Nuveta.

When was Netia Medical Technologies founded?

Netia Medical Technologies was founded in 1989.

Where is Netia Medical Technologies' headquarters located?

Netia Medical Technologies' headquarters is located in Omaha, NE, US.

When was Netia Medical Technologies' last funding round?

Netia Medical Technologies' most recent funding round was for $800k (USD) in November 2010.

How much disclosed funding has Netia Medical Technologies raised?

Netia Medical Technologies - Classification

Ownership: Private
Venture-backed
Technology: Biotech
Geographic Exposure: United States

As of Nov 23, 2010, Netia Medical Technologies has disclosed funding of $800k (USD). Undisclosed round amounts are excluded.

How many employees does Netia Medical Technologies have?

Netia Medical Technologies has 5 employees as of Feb 4, 2024.

Revenue: Licensing
Recurring
Customer: Enterprise
Main Product: Drug Development

Tags: Biotech
Platform

NAICS: 620000Health Care and Social Assistance
SIC: 8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Nuveta

nuveta.com

Neumedics

neumedics.com

Nano RED

Novita Therapeutics

Nerx Biosciences

NX Pharmagen

nxpharmagen.com

Rumi Scientific

rumiscientific.com

ReviR Therapeutics

revirtx.com

PeptiMed

peptimed.com

Nextrna Therapeutics

Ionis Pharmaceuticals

ionispharma.com

Phio Pharmaceuticals

phiopharma.com